financetom
Business
financetom
/
Business
/
Tiremaker Titan's Q2 revenue misses analyst estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tiremaker Titan's Q2 revenue misses analyst estimates
Jul 31, 2025 3:22 AM

Overview

* Titan Q2 revenue of $461 mln, , within company guidance but missing analyst expectations

* Adjusted EBITDA for Q2 was $30 mln, within company guidance

* Company maintained 15% gross margin amid interest rate and tariff challenges

Outlook

* Titan expects Q3 sales between $450 mln and $475 mln

* Company forecasts Q3 adjusted EBITDA of $25 mln to $30 mln

* Titan sees macro tailwinds aiding future financial results

* Company anticipates inventory levels to drive upward sales trend

Result Drivers

* MARKET CHALLENGES - Higher interest rates and tariff uncertainties impacted end markets, per CEO Paul Reitz

* INVENTORY LEVELS - Co sees wheel and tire inventories reaching levels where growth is expected, per CEO Paul Reitz

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Miss $461 mln $478 mln

(5

Analysts

)

Q2 $30 mln

Adjusted

EBITDA

Q2 Gross 15.0%

Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the auto, truck & motorcycle parts peer group is "buy"

* Wall Street's median 12-month price target for Titan International Inc ( TWI ) is $11.00, about 17.5% above its July 30 closing price of $9.07

* The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 24 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Express Wash Concepts Expands Greater Cincinnati Presence with Acquisition of Montgomery Road Zips Car Wash Location
Express Wash Concepts Expands Greater Cincinnati Presence with Acquisition of Montgomery Road Zips Car Wash Location
Oct 24, 2025
COLUMBUS, Ohio, and CINCINNATI, Oct. 24, 2025 /PRNewswire/ -- Express Wash Concepts (EWC), one of the nation's fastest-growing express car wash operators, today announced the continued expansion of its Flying Ace Express Car Wash brand through the acquisition of a new site located at 12167 Montgomery Road in Cincinnati, Ohio. This strategic addition strengthens EWC's growing presence across Greater Cincinnati and increases the...
Biogen Gets Worldwide Rights to Vanqua Bio's Preclinical Drug Candidate for Inflammatory Disorders
Biogen Gets Worldwide Rights to Vanqua Bio's Preclinical Drug Candidate for Inflammatory Disorders
Oct 24, 2025
08:34 AM EDT, 10/24/2025 (MT Newswires) -- Biogen (BIIB) said Friday it has been granted exclusive worldwide rights to biopharmaceutical company Vanqua Bio's preclinical drug candidate for inflammatory disorders. Under the terms of the deal, Biogen will pay $70 million upfront to Vanqua, with up to $990 million in potential milestone payments, along with tiered royalties on potential net sales....
Blackstone to Invest $705 Million in India's Federal Bank
Blackstone to Invest $705 Million in India's Federal Bank
Oct 24, 2025
08:33 AM EDT, 10/24/2025 (MT Newswires) -- Blackstone (BX) will invest about $705 million in India's Federal Bank for a 9.9% stake through a Singapore-based affiliate, the Indian lender disclosed and Reuters reported on Friday. The deal will make Blackstone the largest shareholder in the bank, Reuters reported. The investment will be made through Asia II Topco XIII, Federal Bank...
Genenta Extends Collaboration With Anemocyte To Boost Off-The-Shelf Genetic Therapy Production
Genenta Extends Collaboration With Anemocyte To Boost Off-The-Shelf Genetic Therapy Production
Oct 24, 2025
Genenta Science shares traded higher in Friday's premarket after the company unveiled an expanded collaboration with biotechnology firm ANEMOCYTE. The partnership aims to advance the development of off-the-shelf lentiviral vector Plasmid DNA technology. The two companies are building on an already successful working relationship centered on Plasmid DNA manufacturing. Also Read: Eni CEO Sees Resilient Growth Despite Unfavorable Oil And...
Copyright 2023-2026 - www.financetom.com All Rights Reserved